31 Jul 2024
Agenda for the November 2024 PBAC meeting – 31 July 2024
Agenda for the November 2024 PBAC meeting – 31 July 2024
19 Jul 2024
PBAC Public Summary Documents – March 2024 meeting (first time decisions not to recommend and deferrals)
PBAC Public Summary Documents – March 2024 meeting (first time decisions not to recommend and deferrals)
19 Jul 2024
Drug Utilisation Sub-Committee (DUSC) Outcome Statement 19 July
Drug Utilisation Sub-Committee (DUSC) Outcome Statement
11 Jul 2024
Updates to the HTA Policy and Methods Review
The Health Technology Assessment (HTA) Policy and Methods Review concluded on 4 May 2024. The HTA Review Reference Committee which was responsible for overseeing the HTA Review, held its final meeting on 2 May 2024.
08 Jul 2024
Post-market Review workplan (May 2024) published
Post-market Review workplan (May 2024) published
05 Jul 2024
PBAC Public Summary Documents – March 2024 meeting
PBAC Public Summary Documents – March 2024 meeting
01 Jul 2024
Update - 13485R - CALCIUM, calcium carbonate 1.25 g (calcium 500 mg) chewable tablet, 120 (Cal-500) – Prescriber code permissions
An error in the July 2024 PBS schedule has resulted in Nurse practitioners not being able to prescribe Calcium for stable patients suitable for the increased maximum dispensed quantity measure (maximum quantity of 4) item code 13485R. The error will be rectified 1 August 2024.
